Biofil Liabilities And Stockholders Equity from 2010 to 2025
| BIOFILCHEM | 49.97 1.24 2.54% |
Liabilities And Stockholders Equity | First Reported 2009-03-31 | Previous Quarter 470.8 M | Current Value 420.4 M | Quarterly Volatility 109.2 M |
Check Biofil Chemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofil Chemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 354.8 K or Total Revenue of 483.4 M, as well as many indicators such as . Biofil financial statements analysis is a perfect complement when working with Biofil Chemicals Valuation or Volatility modules.
Biofil | Liabilities And Stockholders Equity |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.